Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac 3% gel vs Solaraze vs vehicle in actinic keratosis (Phase 3)
2014-001621-33Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in actinic keratosis (AK) (3 arms), sponsored by Dermapharm. Primary endpoint: Primary - TLNS reduction ≥75% at final examination (per protocol population). Started Jun 2014; status: completed.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2014-001621-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001621-33.